This multibagger pharma stock turns Rs 10,000 to Rs 2.7 lakh in 10 years. Should you buy?
Caplin Point Laboratories, which is engaged in developing and marketing a range of generic formulations, has seen a stellar rally in the last 10 year period, rising as much as …
